Cancer Testing/Screening Market - Forecast(2022 - 2027)

Report Code: HCR 0078 Report Format: PDF + Excel

Cancer Testing Screening Market Overview

Cancer Testing Screening Market size is projected to reach $220.66 billion by 2027 and is expected to grow at a CAGR of 6.4% during the forecast period 2022-2027. Cancer Testing and Screening are vital procedures for aid in the early detection of cancer before symptoms occur. It lowers the risk of malignant cells growing abnormally and lowers the person's mortality rates. Each type of cancer has a screening test that can help spot cancer early on. There is increasing adoption of cancer screening tests, particularly in countries with the highest cancer rates. The improved research and development activities coupled with the increasing public awareness of cancer diseases are all predicted to create a new window of opportunities in the global cancer Testing screening market. However, COVID-19 has restrained the market growth. The lack of adequate supplies needs for more service providers added to the crises, thereby restraining the market growth.

Cancer Testing Screening Market Report Coverage

The report: “Cancer Testing Screening Market Forecast (2022-2027)”, by Industry ARC, covers an in-depth analysis of the following segments of the Cancer Testing Screening Market.

By Type: Diagnostics, Screening.
By Cancer Type: Respiratory System Cancer, Leukemia, Myeloma and Lymphoma, Skin Cancer, Abdominal/Digestive System Cancer, Genital Cancer, Oral Cancer, Urinary System Cancer, Endocrine System Cancer, Breast Cancer, Others.
By Technique: Imaging, Biopsy, Genomic and Molecular Tests (Next Generation Sequencing, RT-PCR, Microarrays, Biomarker Testing, Others.
By Product Type: Molecular Diagnostics, Companion Diagnostics.
By Stage: Terminal, Stage 0-4, Prognosis, Other Staging System.
By Gender: Male, Female.
By Geography: Americas (U.S, Canada, Brazil, Rest of Americas), Europe (U.K, Germany, France, Italy, Spain and Rest of Europe), Asia-Pacific (China, Japan, India, and South Korea), and Rest of the World (Middle East, Africa).

Key Takeaways

  • Geographically, The Americas Cancer Testing Screening market accounted for the highest revenue share in 2021, followed by Europe. This is owing to the steady rise of Lung and Prostate Cancer cases in both regions which are being driven by the adoption of unhealthy lifestyles such as excessive alcohol consumption and smoking.
  • The increasing number of cancer cases around the world is unfortunate. However, it is beneficial to the cancer screening industry. The industry is also being propelled forward by Increased research and development (R&D) to develop effective cancer treatments and early detection. Innovative technologies including positron emission mammography, spectroscopy-enhanced colonoscopy, and hyperpolarization MRI, among others, are improving screening efficiency.
  • Cancer Testing Screening Market Detailed Analysis on the Strength, Weakness, and Opportunities of the prominent players operating in the market will be provided in the Cancer Testing Screening Market report.

Cancer Testing Screening Market: Market Share (%) by Region, 2021 

Cancer Testing Screening Market

For more details on this report - Request for Sample

Cancer Testing Screening Market Segment Analysis – By Cancer Type

The Cancer Testing Screening Market based on Cancer Type can be segmented into Respiratory System Cancer, Leukemia, Myeloma, and Lymphoma, Skin Cancer, Abdominal/Digestive System Cancer, Genital Cancer, Oral Cancer, Urinary System Cancer, Endocrine System Cancer, Breast Cancer, and Others. Abdominal/Digestive system cancer had the largest share in the cancer testing screening market in 2021 and is expected to grow at a CAGR of 5.9% owing to the rise in consumption of processed food and alcohol. Additionally, the increase in the global geriatric population has generated demand for imaging devices for early detection and treatment of Abdominal cancer, thereby driving the segment. According to the Organization of the United Nations, the proportion of people aged 65 and up in the global population climbed from 6% in 1990 to 9% in 2019. By 2050, that percentage is expected to climb to 16%, implying that one in every six individuals on the planet is predicted to be 65 or older.

Cancer Testing Screening Market Segment Analysis – By Technique

The Cancer Testing Screening Market based on the Technique can be segmented into Imaging, Biopsy, Genomic and Molecular Tests (Next Generation Sequencing, RT-PCR, Microarrays, Biomarker Testing, and Others. Biopsy technique dominated the Cancer testing screening Market in 2021 and is expected to grow at a CAGR of 6.2%. This is owing to its high accuracy during Cancer Diagnosis. Other Diagnostic advances, such as imaging techniques, have increased demand for cancer testing and screening. Imaging has become an important aspect of cancer detection and diagnosis, with recent advancements in tumor imaging technologies improving the diagnosis of five common cancers, including breast, lung, prostate, and colorectal cancers.

Cancer Testing Screening Market Segment Analysis – By Geography

The Cancer Testing Screening Market based on Geography can be segmented into Americas, Europe, Asia-Pacific, and the Rest of the World. Americas region dominated the cancer screening/testing market in 2021 with a market share of 41% and is growing at a CAGR of 4.5% during the forecast period 2022-2027. This is owing to the high rate of new cancer cases each year along with increased awareness amongst the masses.

 However, Asia Pacific is set to be the fastest-growing segment with a CAGR of 11% during the forecast period 2022-2027. This is owing to the growing rate of endocrine, abdominal, leukemia, myeloma, and lymphoma cancers in the Asia Pacific region. 

Cancer Testing Screening Market Drivers

Growing Number Of Cancer Screening Awareness Campaigns To Raise Awareness About The Importance Of Early Detection Of Breast Cancer Is To Drive Market Growth

Several governmental and commercial groups are launching various campaigns to raise awareness about the importance of early detection of breast cancer, the second most frequent cancer among women in the United States. Breast Cancer Diagnostics Market Growth Depends on Cancer Awareness Campaigns. Nations around the globe have initiated various Cancer Screening Awareness Campaigns to encourage young people to make these life-saving behaviors part of their daily routine. For example, Breast cancer campaigns, Cervical cancer awareness campaigns, Protect Your Skin campaigns, Ovarian cancer awareness campaigns and Colorectal cancer awareness campaigns are among the few impacting the growth of the cancer screening and diagnostics market. For instance, the 'Be Clear on Cancer campaign has substantially increased the number of referrals under the 2WW rule. This has increased demands on both resources (59% more tests) and finance. Cost per cancer detected rose by 27% with no increase in funding to support the increased activity.

Technological Advancements And Automation In Cancer Testing And Screening Is To Fuel Service Demand

Cancer testing has become more accurate and user-friendly as a result of technological developments and automation, which has aided industry growth. Novel screening technologies have largely been adopted owing to their ability to increase tumor detection rates. Additionally, the cancer testing & screening market is likely to be driven by the approval of novel biomarkers and increased R&D spending. The key players in the market are increasingly investing in AI-based imaging biomarkers. For instance, Brainomix has invested $21.2 million for the development of an AI platform that automates validated imaging biomarkers to improve both diagnosis and treatment decisions to build on the proven success of the company's tech platform in stroke and enable value-generating pharmaceutical partnerships. Proteomics and genomics are two OMICS technologies that will propel the cancer testing & screening industry forward.

Cancer Testing Screening Market Challenges

High Cost Of Cancer Diagnosis And Increased Financial Burden To Hamper The Market Growth

Cancer has a significant financial impact on patients and their families. Today, the estimated 16.1 million cancer patients face annual out-of-pocket medical expenses that are 61% higher than those who do not have cancer. Cancer patients had higher out-of-pocket costs than non-cancer patients, with high-deductible health plans having the greatest out-of-pocket costs. According to a report by the National Coalition of Cancer Survivorship 47% of cancer patients reported financial burden in cancer care.

Cancer Testing Screening Industry Outlook

Product Launch, Collaboration, and Acquisitions key strategies adopted by players in the Cancer Testing Screening Market. In 2020, the Cancer Testing Screening Market share is consolidated by the top ten players present in the market. In the Cancer Testing Screening Market, the top 10 companies are-

  1. DiaSorin S.p.A
  2. Immunodiagnostic Systems Holdings Ltd
  3. Epigenomics AG
  4. Quest Diagnostics Inc.
  5. F. Hoffmann-La Roche Ltd
  6. VolitionRX Limited
  7. Abbott Laboratories
  8. QIAGEN GmbH
  9. Siemens Healthineers AG
  10. Becton, Dickinson, and Company

Recent Developments

  • In January 2022, Siemens Healthineers, through its subsidiary Varian entered into a ten-year strategic partnership with Oulu University Hospital in Finland, to build a comprehensive digital, diagnostic and therapeutic ecosystem that addresses the entire cancer treatment pathway. Siemens will supply a technology and services package to Oulu University Hospital that includes cancer imaging and radiation therapy equipment, software solutions for enhanced workflow and decision support, and related support services.
  • In February 2022, Becton, Dickinson, and Company acquired Cytognos, a company specializing in flow cytometry solutions for blood cancer diagnosis, minimal residual disease (MRD) detection, and immune monitoring research for blood diseases. The acquisition enables BD to enhance chronic illness management by increasing its offering of blood cancer diagnostics, immunological assessment tests, and informatics.
  • In October 2021, Roche entered into a collaboration with PathAI, a global leader in artificial intelligence (AI)-powered technology for pathology. Under the agreement, the companies are to jointly develop an embedded image analysis workflow for pathologists, which can benefit cancer patients through more precise diagnosis. 

Relevant Titles:

Cancer Biomarkers Market Forecast (2022-2027)

Report Code: HCR 0194

Cancer Diagnostics Market - Forecast(2022 - 2027)

Report Code: HCR 0195

Oncology Clinical Trials Market - Forecast(2022 - 2027)

Report Code: HCR 1377

For more Lifesciences and Healthcare related reports, please click here

 1. Cancer Testing Screening Market - Overview
    1.1. Definitions and Scope
2. Cancer Testing Screening Market - Executive Summary
3. Cancer Testing Screening Market Landscape
    3.1. Company Benchmarking- Key Companies
    3.2. Financial Analysis - Key Companies
    3.3. Market Share Analysis- Key Companies
    3.4. Patent Analysis - Global
    3.5. Pricing Analysis – Average Price
4. Cancer Testing Screening Market- Startup Companies Scenario Premium
    4.1. Investment
    4.2. Revenue
    4.3. Venture Capital and Funding Scenario
5. Cancer Testing Screening Market- Industry Market Entry Scenario Premium Premium
    5.1. Regulatory Framework Overview
    5.2. New Business and Ease of Doing Business Index
    5.3. Case Studies of Successful Ventures
6. Cancer Testing Screening Market - Market Forces
    6.1. Market Drivers
    6.2. Market Constraints & Challenges
    6.3. Porters five force model
        6.3.1. Bargaining power of suppliers
        6.3.2. Bargaining powers of customers
        6.3.3. Threat of new entrants
        6.3.4. Rivalry among existing players
        6.3.5. Threat of substitutes 
7. Cancer Testing Screening Market - By Strategic Analysis 
    7.1. Value Chain Analysis
    7.2. Opportunities Analysis
    7.3. Market Life Cycle Analysis
8. Cancer Testing Screening Market – By Type (Market Size –$Million/$Billion)
    8.1. Diagnostics
    8.2. Screening
9. Cancer Testing Screening Market – By Cancer Type (Market Size –$Million/$Billion)
    9.1. Respiratory System Cancer
    9.2. Leukemia, Myeloma and Lymphoma 
    9.3. Skin Cancer
    9.4. Abdominal/ Digestive System Cancer
    9.5. Genital Cancer
    9.6. Oral Cancer
    9.7. Urinary System Cancer
    9.8. Endocrine System Cancer
    9.9. Breast Cancer
    9.10. Others
10. Cancer Testing Screening Market – By Technique (Market Size –$Million/$Billion)
    10.1. Imaging
    10.2. Biopsy
    10.3. Genomic and Molecular Tests
        10.3.1. Next-Generation Sequencing (NGS)
        10.3.2. RT-PCR
        10.3.3. Biomarker Testing
        10.3.4. Others 
    10.4. Lab Based Tests
11. Cancer Testing Screening Market- By Product Type (Market Size –$Million/$Billion) 
    11.1. Molecular Diagnostics
    11.2. Companion Diagnostics
12. Cancer Testing Screening Market- By Stage (Market Size –$Million/$Billion) 
    12.1. Terminal
    12.2. Stage 0,1,2,3,4
    12.3. Prognosis
    12.4. Other Staging System
13. Cancer Testing Screening Market- By Gender (Market Size –$Million/$Billion) 
    13.1. Male
    13.2. Female
14. Cancer Testing Screening Market - By Geography 
    14.1. Americas
        14.1.1. U.S
        14.1.2. Canada
        14.1.3. Brazil
        14.1.4. Rest of Americas
    14.2. Europe 
        14.2.1. U.K 
        14.2.2. Germany 
        14.2.3. France
        14.2.4. Italy
        14.2.5. Spain
        14.2.6. Rest of Europe
    14.3. Asia Pacific
        14.3.1. China
        14.3.2. Australia & New Zealand
        14.3.3. Japan
        14.3.4. India
        14.3.5. South Korea
        14.3.6. Rest of Asia Pacific
    14.4. Rest of World
        14.4.1. Middle East
        14.4.2. Africa
15. Cancer Testing Screening Market- Entropy
16. Cancer Testing Screening Market – Industry/Segment Competition Landscape Premium
    16.1. Market Share Analysis
        16.1.1. Market Share by Region – Key companies
        16.1.2. Market Share by Country- Key companies
    16.2. Competition Matrix
    16.3. Best Practices for Companies
17. Cancer Testing Screening Market – Key Companies List by Countries Premium
18. Cancer Testing Screening Market – Key Company Profiles (Overview, Financials, Developments, Product Portfolio)
    18.1. Company 1
    18.2. Company 2
    18.3. Company 3
    18.4. Company 4
    18.5. Company 5
    18.6. Company 6
    18.7. Company 7
    18.8. Company 8
    18.9. Company 9
    18.10. Company 10
"*Financials would be provided on a best efforts basis for private companies"
List of Tables:
Table 1: Cancer Testing/Screening Market Overview 2021-2026
Table 2: Cancer Testing/Screening Market Leader Analysis 2018-2019 (US$)
Table 3: Cancer Testing/Screening Market Product Analysis 2018-2019 (US$)
Table 4: Cancer Testing/Screening Market End User Analysis 2018-2019 (US$)
Table 5: Cancer Testing/Screening Market Patent Analysis 2013-2018* (US$)
Table 6: Cancer Testing/Screening Market Financial Analysis 2018-2019 (US$)
Table 7: Cancer Testing/Screening Market Driver Analysis 2018-2019 (US$)
Table 8: Cancer Testing/Screening Market Challenges Analysis 2018-2019 (US$)
Table 9: Cancer Testing/Screening Market Constraint Analysis 2018-2019 (US$)
Table 10: Cancer Testing/Screening Market Supplier Bargaining Power Analysis 2018-2019 (US$)
Table 11: Cancer Testing/Screening Market Buyer Bargaining Power Analysis 2018-2019 (US$)
Table 12: Cancer Testing/Screening Market Threat of Substitutes Analysis 2018-2019 (US$)
Table 13: Cancer Testing/Screening Market Threat of New Entrants Analysis 2018-2019 (US$)
Table 14: Cancer Testing/Screening Market Degree of Competition Analysis 2018-2019 (US$)
Table 15: Cancer Testing/Screening Market Value Chain Analysis 2018-2019 (US$)
Table 16: Cancer Testing/Screening Market Pricing Analysis 2021-2026 (US$)
Table 17: Cancer Testing/Screening Market Opportunities Analysis 2021-2026 (US$)
Table 18: Cancer Testing/Screening Market Product Life Cycle Analysis 2021-2026 (US$)
Table 19: Cancer Testing/Screening Market Supplier Analysis 2018-2019 (US$)
Table 20: Cancer Testing/Screening Market Distributor Analysis 2018-2019 (US$)
Table 21: Cancer Testing/Screening Market Trend Analysis 2018-2019 (US$)
Table 22: Cancer Testing/Screening Market Size 2018 (US$)
Table 23: Cancer Testing/Screening Market Forecast Analysis 2021-2026 (US$)
Table 24: Cancer Testing/Screening Market Sales Forecast Analysis 2021-2026 (Units)
Table 25: Cancer Testing/Screening Market, Revenue & Volume, By Type, 2021-2026 ($)
Table 26: Cancer Testing/Screening Market By Type, Revenue & Volume, By Lung Cancer, 2021-2026 ($)
Table 27: Cancer Testing/Screening Market By Type, Revenue & Volume, By Blood Cancer, 2021-2026 ($)
Table 28: Cancer Testing/Screening Market By Type, Revenue & Volume, By Bone Cancer, 2021-2026 ($)
Table 29: Cancer Testing/Screening Market By Type, Revenue & Volume, By Gall Bladder Cancer, 2021-2026 ($)
Table 30: Cancer Testing/Screening Market By Type, Revenue & Volume, By Testicular Cancer, 2021-2026 ($)
Table 31: Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2021-2026 ($)
Table 32: Cancer Testing/Screening Market By Technique, Revenue & Volume, By Imaging Techniques, 2021-2026 ($)
Table 33: Cancer Testing/Screening Market By Technique, Revenue & Volume, By Endoscopy procedure, 2021-2026 ($)
Table 34: Cancer Testing/Screening Market By Technique, Revenue & Volume, By Biopsy and cytology tests, 2021-2026 ($)
Table 35: Cancer Testing/Screening Market By Technique, Revenue & Volume, By Genomic and Molecular tests, 2021-2026 ($)
Table 36: Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2021-2026 ($)
Table 37: Cancer Testing/Screening Market By Treatment, Revenue & Volume, By Surgery, 2021-2026 ($)
Table 38: Cancer Testing/Screening Market By Treatment, Revenue & Volume, By Immunotherapy, 2021-2026 ($)
Table 39: Cancer Testing/Screening Market By Treatment, Revenue & Volume, By Hormone Therapy, 2021-2026 ($)
Table 40: Cancer Testing/Screening Market By Treatment, Revenue & Volume, By Chemo Therapy, 2021-2026 ($)
Table 41: Cancer Testing/Screening Market By Treatment, Revenue & Volume, By Gene Therapy, 2021-2026 ($)
Table 42: Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2021-2026 ($)
Table 43: Cancer Testing/Screening Market By Stage, Revenue & Volume, By TNM Stages, 2021-2026 ($)
Table 44: Cancer Testing/Screening Market By Stage, Revenue & Volume, By Stages 0, 1, 2, 3, 4, 2021-2026 ($)
Table 45: Cancer Testing/Screening Market By Stage, Revenue & Volume, By Prognostic Factors, 2021-2026 ($)
Table 46: Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2021-2026 ($)
Table 47: Cancer Testing/Screening Market By Gender, Revenue & Volume, By Men, 2021-2026 ($)
Table 48: Cancer Testing/Screening Market By Gender, Revenue & Volume, By Women, 2021-2026 ($)
Table 49: North America Cancer Testing/Screening Market, Revenue & Volume, By Type, 2021-2026 ($)
Table 50: North America Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2021-2026 ($)
Table 51: North America Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2021-2026 ($)
Table 52: North America Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2021-2026 ($)
Table 53: North America Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2021-2026 ($)
Table 54: South america Cancer Testing/Screening Market, Revenue & Volume, By Type, 2021-2026 ($)
Table 55: South america Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2021-2026 ($)
Table 56: South america Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2021-2026 ($)
Table 57: South america Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2021-2026 ($)
Table 58: South america Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2021-2026 ($)
Table 59: Europe Cancer Testing/Screening Market, Revenue & Volume, By Type, 2021-2026 ($)
Table 60: Europe Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2021-2026 ($)
Table 61: Europe Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2021-2026 ($)
Table 62: Europe Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2021-2026 ($)
Table 63: Europe Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2021-2026 ($)
Table 64: APAC Cancer Testing/Screening Market, Revenue & Volume, By Type, 2021-2026 ($)
Table 65: APAC Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2021-2026 ($)
Table 66: APAC Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2021-2026 ($)
Table 67: APAC Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2021-2026 ($)
Table 68: APAC Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2021-2026 ($)
Table 69: Middle East & Africa Cancer Testing/Screening Market, Revenue & Volume, By Type, 2021-2026 ($)
Table 70: Middle East & Africa Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2021-2026 ($)
Table 71: Middle East & Africa Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2021-2026 ($)
Table 72: Middle East & Africa Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2021-2026 ($)
Table 73: Middle East & Africa Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2021-2026 ($)
Table 74: Russia Cancer Testing/Screening Market, Revenue & Volume, By Type, 2021-2026 ($)
Table 75: Russia Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2021-2026 ($)
Table 76: Russia Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2021-2026 ($)
Table 77: Russia Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2021-2026 ($)
Table 78: Russia Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2021-2026 ($)
Table 79: Israel Cancer Testing/Screening Market, Revenue & Volume, By Type, 2021-2026 ($)
Table 80: Israel Cancer Testing/Screening Market, Revenue & Volume, By Technique, 2021-2026 ($)
Table 81: Israel Cancer Testing/Screening Market, Revenue & Volume, By Treatment, 2021-2026 ($)
Table 82: Israel Cancer Testing/Screening Market, Revenue & Volume, By Stage, 2021-2026 ($)
Table 83: Israel Cancer Testing/Screening Market, Revenue & Volume, By Gender, 2021-2026 ($)
Table 84: Top Companies 2018 (US$) Cancer Testing/Screening Market, Revenue & Volume
Table 85: Product Launch 2018-2019 Cancer Testing/Screening Market, Revenue & Volume
Table 86: Mergers & Acquistions 2018-2019 Cancer Testing/Screening Market, Revenue & Volume

List of Figures:

Figure 1: Overview of Cancer Testing/Screening Market 2021-2026
Figure 2: Market Share Analysis for Cancer Testing/Screening Market 2018 (US$)
Figure 3: Product Comparison in Cancer Testing/Screening Market 2018-2019 (US$)
Figure 4: End User Profile for Cancer Testing/Screening Market 2018-2019 (US$)
Figure 5: Patent Application and Grant in Cancer Testing/Screening Market 2013-2018* (US$)
Figure 6: Top 5 Companies Financial Analysis in Cancer Testing/Screening Market 2018-2019 (US$)
Figure 7: Market Entry Strategy in Cancer Testing/Screening Market 2018-2019
Figure 8: Ecosystem Analysis in Cancer Testing/Screening Market 2018
Figure 9: Average Selling Price in Cancer Testing/Screening Market 2021-2026
Figure 10: Top Opportunites in Cancer Testing/Screening Market 2018-2019
Figure 11: Market Life Cycle Analysis in Cancer Testing/Screening Market
Figure 12: GlobalBy Type Cancer Testing/Screening Market Revenue, 2021-2026 ($)
Figure 13: GlobalBy Technique Cancer Testing/Screening Market Revenue, 2021-2026 ($)
Figure 14: GlobalBy Treatment Cancer Testing/Screening Market Revenue, 2021-2026 ($)
Figure 15: GlobalBy Stage Cancer Testing/Screening Market Revenue, 2021-2026 ($)
Figure 16: GlobalBy Gender Cancer Testing/Screening Market Revenue, 2021-2026 ($)
Figure 17: Global Cancer Testing/Screening Market - By Geography
Figure 18: Global Cancer Testing/Screening Market Value & Volume, By Geography, 2021-2026 ($) 
Figure 19: Global Cancer Testing/Screening Market CAGR, By Geography, 2021-2026 (%)
Figure 20: North America Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 21: US Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 22: US GDP and Population, 2018-2019 ($)
Figure 23: US GDP – Composition of 2018, By Sector of Origin
Figure 24: US Export and Import Value & Volume, 2018-2019 ($)
Figure 25: Canada Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 26: Canada GDP and Population, 2018-2019 ($)
Figure 27: Canada GDP – Composition of 2018, By Sector of Origin
Figure 28: Canada Export and Import Value & Volume, 2018-2019 ($)
Figure 29: Mexico Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 30: Mexico GDP and Population, 2018-2019 ($)
Figure 31: Mexico GDP – Composition of 2018, By Sector of Origin
Figure 32: Mexico Export and Import Value & Volume, 2018-2019 ($)
Figure 33: South America Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 34: Brazil Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 35: Brazil GDP and Population, 2018-2019 ($)
Figure 36: Brazil GDP – Composition of 2018, By Sector of Origin
Figure 37: Brazil Export and Import Value & Volume, 2018-2019 ($)
Figure 38: Venezuela Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 39: Venezuela GDP and Population, 2018-2019 ($)
Figure 40: Venezuela GDP – Composition of 2018, By Sector of Origin
Figure 41: Venezuela Export and Import Value & Volume, 2018-2019 ($)
Figure 42: Argentina Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 43: Argentina GDP and Population, 2018-2019 ($)
Figure 44: Argentina GDP – Composition of 2018, By Sector of Origin
Figure 45: Argentina Export and Import Value & Volume, 2018-2019 ($)
Figure 46: Ecuador Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 47: Ecuador GDP and Population, 2018-2019 ($)
Figure 48: Ecuador GDP – Composition of 2018, By Sector of Origin
Figure 49: Ecuador Export and Import Value & Volume, 2018-2019 ($)
Figure 50: Peru Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 51: Peru GDP and Population, 2018-2019 ($)
Figure 52: Peru GDP – Composition of 2018, By Sector of Origin
Figure 53: Peru Export and Import Value & Volume, 2018-2019 ($)
Figure 54: Colombia Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 55: Colombia GDP and Population, 2018-2019 ($)
Figure 56: Colombia GDP – Composition of 2018, By Sector of Origin
Figure 57: Colombia Export and Import Value & Volume, 2018-2019 ($)
Figure 58: Costa Rica Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 59: Costa Rica GDP and Population, 2018-2019 ($)
Figure 60: Costa Rica GDP – Composition of 2018, By Sector of Origin
Figure 61: Costa Rica Export and Import Value & Volume, 2018-2019 ($)
Figure 62: Europe Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 63: U.K Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 64: U.K GDP and Population, 2018-2019 ($)
Figure 65: U.K GDP – Composition of 2018, By Sector of Origin
Figure 66: U.K Export and Import Value & Volume, 2018-2019 ($)
Figure 67: Germany Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 68: Germany GDP and Population, 2018-2019 ($)
Figure 69: Germany GDP – Composition of 2018, By Sector of Origin
Figure 70: Germany Export and Import Value & Volume, 2018-2019 ($)
Figure 71: Italy Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 72: Italy GDP and Population, 2018-2019 ($)
Figure 73: Italy GDP – Composition of 2018, By Sector of Origin
Figure 74: Italy Export and Import Value & Volume, 2018-2019 ($)
Figure 75: France Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 76: France GDP and Population, 2018-2019 ($)
Figure 77: France GDP – Composition of 2018, By Sector of Origin
Figure 78: France Export and Import Value & Volume, 2018-2019 ($)
Figure 79: Netherlands Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 80: Netherlands GDP and Population, 2018-2019 ($)
Figure 81: Netherlands GDP – Composition of 2018, By Sector of Origin
Figure 82: Netherlands Export and Import Value & Volume, 2018-2019 ($)
Figure 83: Belgium Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 84: Belgium GDP and Population, 2018-2019 ($)
Figure 85: Belgium GDP – Composition of 2018, By Sector of Origin
Figure 86: Belgium Export and Import Value & Volume, 2018-2019 ($)
Figure 87: Spain Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 88: Spain GDP and Population, 2018-2019 ($)
Figure 89: Spain GDP – Composition of 2018, By Sector of Origin
Figure 90: Spain Export and Import Value & Volume, 2018-2019 ($)
Figure 91: Denmark Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 92: Denmark GDP and Population, 2018-2019 ($)
Figure 93: Denmark GDP – Composition of 2018, By Sector of Origin
Figure 94: Denmark Export and Import Value & Volume, 2018-2019 ($)
Figure 95: APAC Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 96: China Cancer Testing/Screening Market Value & Volume, 2021-2026
Figure 97: China GDP and Population, 2018-2019 ($)
Figure 98: China GDP – Composition of 2018, By Sector of Origin
Figure 99: China Export and Import Value & Volume, 2018-2019 ($) Cancer Testing/Screening Market China Export and Import Value & Volume, 2018-2019 ($)
Figure 100: Australia Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 101: Australia GDP and Population, 2018-2019 ($)
Figure 102: Australia GDP – Composition of 2018, By Sector of Origin
Figure 103: Australia Export and Import Value & Volume, 2018-2019 ($)
Figure 104: South Korea Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 105: South Korea GDP and Population, 2018-2019 ($)
Figure 106: South Korea GDP – Composition of 2018, By Sector of Origin
Figure 107: South Korea Export and Import Value & Volume, 2018-2019 ($)
Figure 108: India Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 109: India GDP and Population, 2018-2019 ($)
Figure 110: India GDP – Composition of 2018, By Sector of Origin
Figure 111: India Export and Import Value & Volume, 2018-2019 ($)
Figure 112: Taiwan Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 113: Taiwan GDP and Population, 2018-2019 ($)
Figure 114: Taiwan GDP – Composition of 2018, By Sector of Origin
Figure 115: Taiwan Export and Import Value & Volume, 2018-2019 ($)
Figure 116: Malaysia Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 117: Malaysia GDP and Population, 2018-2019 ($)
Figure 118: Malaysia GDP – Composition of 2018, By Sector of Origin
Figure 119: Malaysia Export and Import Value & Volume, 2018-2019 ($)
Figure 120: Hong Kong Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 121: Hong Kong GDP and Population, 2018-2019 ($)
Figure 122: Hong Kong GDP – Composition of 2018, By Sector of Origin
Figure 123: Hong Kong Export and Import Value & Volume, 2018-2019 ($)
Figure 124: Middle East & Africa Cancer Testing/Screening Market Middle East & Africa 3D Printing Market Value & Volume, 2021-2026 ($)
Figure 125: Russia Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 126: Russia GDP and Population, 2018-2019 ($)
Figure 127: Russia GDP – Composition of 2018, By Sector of Origin
Figure 128: Russia Export and Import Value & Volume, 2018-2019 ($)
Figure 129: Israel Cancer Testing/Screening Market Value & Volume, 2021-2026 ($)
Figure 130: Israel GDP and Population, 2018-2019 ($)
Figure 131: Israel GDP – Composition of 2018, By Sector of Origin
Figure 132: Israel Export and Import Value & Volume, 2018-2019 ($)
Figure 133: Entropy Share, By Strategies, 2018-2019* (%) Cancer Testing/Screening Market 
Figure 134: Developments, 2018-2019* Cancer Testing/Screening Market 
Figure 135: Company 1 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 136: Company 1 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 137: Company 1 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 138: Company 2 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 139: Company 2 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 140: Company 2 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 141: Company 3 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 142: Company 3 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 143: Company 3 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 144: Company 4 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 145: Company 4 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 146: Company 4 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 147: Company 5 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 148: Company 5 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 149: Company 5 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 150: Company 6 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 151: Company 6 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 152: Company 6 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 153: Company 7 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 154: Company 7 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 155: Company 7 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 156: Company 8 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure : : Company 8 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 158: Company 8 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 159: Company 9 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 160: Company 9 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 161: Company 9 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 162: Company 10 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 163: Company 10 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 164: Company 10 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 165: Company 11 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 166: Company 11 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 167: Company 11 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 168: Company 12 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 169: Company 12 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 170: Company 12 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 171: Company 13 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 172: Company 13 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 173: Company 13 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 174: Company 14 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 175: Company 14 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 176: Company 14 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)
Figure 177: Company 15 Cancer Testing/Screening Market Net Revenue, By Years, 2018-2019* ($)
Figure 178: Company 15 Cancer Testing/Screening Market Net Revenue Share, By Business segments, 2018 (%)
Figure 179: Company 15 Cancer Testing/Screening Market Net Sales Share, By Geography, 2018 (%)